Ageloss
Ageloss is a Joint & Bone supplement from Nature's Plus, receiving an N+ Score of 73 and a C+ grade. This product includes 7.5mg of Zinc and 1mg of Copper, both at clinically studied doses, which may support bone health and immune function. Other ingredients include 300mg of MSM, 300mg of Alpha Lipoic Acid, and 100mg of N-Acetyl Cysteine, commonly used for antioxidant support. With a total of 6 ingredients and 100% label transparency, this formulation focuses on specific micronutrients and compounds. This product may benefit individuals looking for targeted mineral and antioxidant support for joint and bone health.
About This Product
Ageloss by Nature's Plus is a joint & bone supplement containing 6 active ingredients. It has earned an N+ Score of 73/100 (Grade C+).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Zinc, Copper.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +2 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (6 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Zinc | 7.500 mg | Adequate |
| Copper | 1.000 mg | Optimal |
| Alpha Lipoic Acid | 300.000 mg | N/A |
| N-Acetyl Cysteine | 100.000 mg | N/A |
| MSM | 300.000 mg | N/A |
| GliSODin(R) | 125.000 IU | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.